Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, Australia, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers.
Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →
| Demonstração de resultados | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|---|
| Receita total | $2.6B | $2.3B | $1.5B | $872M | $527M | $272M | $149M | $83M | $27M |
| Lucro bruto | $1.7B | $1.7B | $1.2B | $715M | $409M | $204M | $109M | $45M | $8M |
| Margem Bruta % | 64.7% | 73.8% | 79.5% | 82.0% | 77.6% | 75.2% | 73.6% | 54.0% | 29.2% |
| Resultado Operacional (EBIT) | ($93M) | $106M | $62M | ($29M) | ($69M) | ($115M) | ($15M) | ($74M) | ($76M) |
| % de margem operacional | -3.6% | 4.5% | 4.2% | -3.4% | -13.0% | -42.3% | -10.2% | -90.1% | -284.0% |
| Resultado líquido | ($142M) | $128M | $126M | ($24M) | ($66M) | ($108M) | ($18M) | ($72M) | ($75M) |
| Margem Líquida % | -5.5% | 5.5% | 8.5% | -2.7% | -12.5% | -39.6% | -12.2% | -87.3% | -282.0% |
| EBITDA | ($76M) | $178M | $89M | ($12M) | ($58M) | ($107M) | ($14M) | ($71M) | — |
| Lucro por ação (EPS) | $-0.63 | $0.50 | $0.53 | $-0.11 | $-0.32 | $-0.58 | $-0.51 | $-2.07 | $-1.12 |
| Ações em circulação (M) | 232M | 258M | 237M | 209M | 205M | 187M | 35M | 35M | 67M |
Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.
Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de HIMS. /companies/us/HIMS
As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.
About TickerBase · Data methodology & sources · Privacy · Terms